iAspirants
Current AffairsPrelims PYQsUPSC CSE SyllabusUPSC CSE StrategyBlogsPricing
Login
iAspirants

Your AI-powered companion for UPSC preparation.

Quick Links

  • Home
  • About Us
  • Current Affairs
  • Prelims PYQs
  • UPSC CSE Syllabus
  • UPSC CSE Strategy
  • Blogs

Company

  • Pricing
  • FAQs
  • Contact Us
  • Login

Legal

  • Privacy Policy
  • Terms & Conditions
  • Return Policy

© 2026 iAspirants, Inc. All rights reserved.

  1. Blogs
  2. Science and Technology

Biotechnology Conclave 2026 in Chennai

Published on: 09-Sep-2026

Source: The Hindu

Share this post

Biotechnology Conclave 2026 in Chennai

Article Summary

Biotechnology Conclave 2026 Overview

  • Event: Biotech Conclave 2026
  • Date: September 11, 2026
  • Location: Vellore Institute of Technology (VIT), Chennai
  • Inaugurator: Dr. Suchitra Ella, President of CII and co-founder of Bharat Biotech
  • President: G. Viswanathan, Founder and Chancellor, VIT

Key Objectives of the Conclave:

  • Bridge laboratory research and practical applications in biotechnology.
  • Educate and inspire students, undergraduates, and researchers in the field of biotechnology.
  • Discuss advancements in healthcare, diagnostics, pharmaceuticals, and sustainability through biotechnology.

Target Audience:

  • Higher secondary students, undergraduates, researchers, and biotechnology aspirants.

Featured Themes and Discussions:

  1. Technology in Biotechnology:

    • Role of technology in accelerating research in biotechnology.
  2. Innovative Solutions:

    • Exploration of gene editing and precision medicine.
  3. Global Biopharma Hub:

    • India’s status as an emerging hub for biopharmaceuticals.
  4. Research & Innovation Ecosystem:

    • Overview of India’s research landscape and its implications.
  5. Funding Landscape:

    • Discussions on funding opportunities for biotechnology research.

Notable Speakers:

  • Professor K. VijayRaghavan
  • Dr. Vasan Sambandamurthy
  • Dr. Vinod Scaria
  • Dr. Ganapathy
  • Dr. Maneesh Paul
  • Dr. Kalpana Gowrishankar
  • Mayur Abhaya
  • Ajay Mahipal

Quotes and Goals:

  • G. V. Selvam (Vice-President, VIT): Emphasized biotechnology’s potential as a pathway to innovation and service to humanity.
  • Sundar Kondur (CRO, The Hindu Group): Highlighted the importance of engaging with the scientific community to inspire curiosity and understanding of biotechnology’s role in India’s future.

Impact:

  • Aims to enhance public engagement with biotechnology.
  • Inspire future scientists and innovators in the healthcare and research sectors.

Technological Focus:

  • Biotechnology is pivotal for solving urgent societal challenges.
  • Importance of biotechnology in sustainable development and healthcare improvement highlighted.

This conclave is a significant event aimed at fostering a deeper understanding and interest in biotechnology within India, bridging discussions between academia, industry, and policymakers.

Key Terms & Concepts

Biotech Conclave 2026Event focused on biotechnology
Vellore Institute of TechnologyHost of the conclave
Bharat BiotechBiotechnology company co-founded by Dr. Suchitra Ella
September 11, 2026Date of the conclave
CII-president designatePosition of Dr. Suchitra Ella
gene editingEmerging technology in biotechnology
precision medicineInnovative approach in healthcare
global biopharma hubIndia's status in biotechnology
research and innovation ecosystemSupporting structure for biotechnological research
funding landscapeFinancial support for biotechnology research

Mind Map for UPSC Civil Services Revision

Turn UPSC Civil Services Current Affairs Into Exam-Ready Notes

Reading Science and Technology current affairs is half the work. Revise them with ready-made notes and test what actually stuck.

  • Daily UPSC Civil Services current affairs analysis
  • Revision notes, mind maps & MCQs
  • Prelims mock tests with instant results

Related UPSC Civil Services Current Affairs Articles

Ebola Vaccine Trials Begin in Congo
Science and Technology24-Oct-2026

Ebola Vaccine Trials Begin in Congo

Ebola Vaccine Clinical Trial in the Democratic Republic of Congo (DRC)

  1. Ebola Outbreak Status:

    • The DRC is experiencing its worst Ebola outbreak, surpassing 9,700 confirmed cases and resulting in over 4,600 fatalities.
  • This outbreak has primarily been attributed to the Bundibugyo species of Ebola, which lacks an approved vaccine or treatment.
  • Vaccine Trial Initiation:

    • The World Health Organisation (WHO) announced the commencement of the first clinical trial for an Ebola vaccine targeting Bundibugyo on October 23, 2026.
    • The trial is named Tumaini, meaning "hope" in Swahili, and commenced with its first vaccination in Bunia, Ituri province, the outbreak's epicenter.
  • Vaccine Candidates and Approach:

    • The trial will evaluate Ervebo, a vaccine approved for the Zaire strain of Ebola, to assess its cross-protection potential against Bundibugyo.
    • It employs a ring vaccination approach, immunizing individuals at high risk, including pregnant women and children aged 12 years and older.
    • The trial aims to include two Bundibugyo-specific vaccines currently in earlier-stage trials:
      • ChAdOx1 adenoviral vector jab (developed by the University of Oxford).
      • mRNA-based vaccine (developed by Moderna).
    • Funding for these efforts has been provided by the Coalition for Epidemic Preparedness Innovations (CEPI).
  • Objectives and Outcomes:

    • The Tumaini trial will rigorously assess the safety, efficacy, and immunogenicity of the candidates.
    • If successful, it may provide critical evidence for vaccine efficacy against Bundibugyo, representing a significant advancement in outbreak response.
    • WHO and CEPI emphasize the importance of robust evidence to support community health responses and enhance preparedness for future outbreaks.
  • Public Health Response:

    • The DRC declared its 17th outbreak of Ebola on May 15, with WHO designating it as a public health emergency of international concern shortly thereafter, indicating the high alert level for global health.
  • Historical Context:

    • Ebola has claimed over 15,000 lives across Africa in the last 50 years, illustrating the disease's enduring threat to public health.
  • Key Takeaways:

    • The Tumaini trial aims to fill a critical void in the Ebola vaccine landscape and potentially transform response strategies for both current and future outbreaks.
    • The involvement of local communities and health authorities is crucial for generating actionable evidence to enhance public health outcomes.
    Vandalur Zoo Reopens After Avian Flu
    Environment and Ecology24-Oct-2026

    Vandalur Zoo Reopens After Avian Flu

    Summary of Key Updates from Arignar Anna Zoological Park (AAZP)

    1. Background Information:

      • The Arignar Anna Zoological Park in Vandalur temporarily closed due to the detection of H5N1 avian influenza in water birds.
    2. Health Measures and Safety Protocols:

      • Disinfection of the zoo and implementation of precautionary measures were executed following confirmation of the influenza by the ICAR-National Institute of High Security Animal Diseases, Bhopal.
      • Bird enclosures have been cordoned off and are currently inaccessible to visitors.
      • The Health Department performed medical screenings for zoo staff, with 26 animal keepers tested using reverse transcription polymerase chain reaction (RT-PCR) methods, all of which returned negative results for the influenza virus.
    3. Monitoring and Compliance:

      • Continuous monitoring of the health of the birds is being conducted by animal care and veterinary teams, with reports indicating the birds remain healthy and active.
      • The zoo administration is adhering to biosecurity and preventive measures as per established guidelines to protect the health of both animals and visitors.
    4. Public Advisory:

      • Visitors are urged to cooperate with zoo staff and comply with the implemented visitor instructions during their visit.
    5. Animal Care Initiatives:

      • A 13-year-old tiger, captured in Gudalur on October 22, was relocated to the Rescue and Rehabilitation Centre at Vandalur for ongoing veterinary care, rehabilitation, and health monitoring.
    6. Conclusion:

      • The measures taken reflect a structured response to ensure both animal welfare and public safety in light of the health scare involving avian influenza, contributing to biosecurity regarding wildlife parks and installations.

    This information highlights critical operational and health safety protocols that the zoo has implemented in response to disease management, emphasizing the importance of animal welfare and public cooperation during health interventions.

    India and Poland Strengthen Strategic Partnership
    International Relations23-Oct-2026

    India and Poland Strengthen Strategic Partnership

    Summary of India-Poland Strategic Partnership Meeting

    Bilateral Relations

    • Meeting: Prime Minister Narendra Modi of India and Polish Prime Minister Donald Tusk discussed the deepening of strategic ties.
    • Key Focus Areas: Defence industry, space technology, digitization, nuclear energy, and counter-terrorism cooperation.

    Economic Data

    • Bilateral Trade Growth: Increased from $1.95 billion in 2013 to $6.36 billion in 2025 (192% growth).
    • Bilateral Trade Target: Agreement to double trade by 2030.
    • GDP Figures: Poland's GDP surpassed $1 trillion; India recorded a growth rate of 7.8% in the last quarter.

    Strategic Initiatives

    • Defence Agreements: Establishment of a defence industry dialogue aimed at fostering cooperation in drone technology and satellite imagery, critical for both nations amidst geopolitical tensions (notable usage in Ukraine and climate of tensions in South Asia).
    • Cultural Relations: Strengthening cooperation in culture, education, sports, and tourism, including the establishment of the Indian Studies Chair in Krakow.
    • Startup Initiatives: Launch of an India-Poland startup bridge focusing on areas like AI, cyber, fintech, and critical minerals.

    International Context

    • Geopolitical Landscape: Acknowledgment of Poland's proximity to the conflict zones (Ukraine-Russia) and India's strategic alignment with Russia.
    • Mutual Support on Global Platforms: Discussions on India's role in proposing peace initiatives (e.g., ceasefire in the Black Sea region).

    Science and Technology

    • Collaboration in Space: Shared goals in advancing the space sector referenced during talks, with a particular emphasis on joint missions and technological exchanges.
    • Education and Technology Initiatives: Plans for hackathons to boost collaboration and innovation among the youth from both countries.

    Remarks and Significance

    • Mutual Respect and Acknowledgment: Tusk praised Modi's leadership amid global instability and emphasized mutual dependency for economic growth and stability in facing political threats (specifically mentions from China).

    Government Schemes:

    • Emphasis on rural entrepreneurship through technology and advancing capabilities in biotechnology and advanced manufacturing via Polish investment.

    International Agreements:

    • Highlighted the importance of the India-European Union Free Trade Agreement, further enhancing trade relations and opportunities.

    These discussions embody a significant step towards bolstering not just bilateral relations but also shared geostrategic interests amid a changing global landscape. The partnership between India and Poland is set against a backdrop of increasing economic collaboration and technological advancements, further anchored by their geographic positions and strategic objectives.

    Japan's Martian Moons Exploration Mission
    Science and Technology21-Oct-2026

    Japan's Martian Moons Exploration Mission

    Summary of Japan's Martian Moons Exploration (MMx) Mission:

    Mission Overview:

    • Agency: Japan Aerospace Exploration Agency (JAXA)
    • Rocket Launch: H3 from Tanegashima Space Center, Japan.
    • Launch Time: 4:40 am JST (1:11 am IST)
    • Objective: Study Martian moons Phobos and Deimos, aiming to retrieve 10 grams of material from Phobos to return to Earth by 2031.

    Scientific Importance:

    • Current Theories on Origins:

      1. Asteroid Capture Theory: Moons are relics from asteroids captured by Mars's gravitational pull.
      2. Collision Theory: Formed from debris after a large impact on Mars.
    • Challenges: The weak gravity of Phobos offers a more manageable environment for landing and taking off compared to Mars.

    Mission Details:

    • Timeline: Five-year round trip, expected arrival at Mars in August 2027; enter quasi-satellite orbit around Phobos.
    • Spacecraft Modules: Comprises propulsion, exploration, and sample return modules.
    • Scientific Instruments: 13 instruments including cameras and spectrometers for topography and chemical analysis.
    • Rover: IDEFIX rover (developed by France's CNES and Germany's DLR) to be deployed on Phobos before sample retrieval.

    Technological Innovations:

    • The mission tests autonomous navigation and landing technologies critical for future Martian missions.

    International Collaboration:

    • Involves partnerships with NASA, European Space Agency (ESA), CNES, DLR, and the Australian Space Agency to share costs and advance collective goals in planetary exploration.

    Strategic Significance:

    • Advances Japan's position as a leader in planetary exploration and reinforces its technological autonomy in space science.
    • Highlights the importance of lunar and Martian bodies for potential staging of crewed missions, given that missions from Phobos require significantly less fuel than direct landings on Mars.

    Historical Context:

    • Builds on Japan's past success with the Hayabusa spacecraft, which successfully retrieved samples from an asteroid in 2010, establishing Japan as a pioneer in sample-return missions.

    This mission aligns with global trends in space exploration, as various nations aim to enhance their capabilities in studying celestial bodies and the potential for human exploration of Mars.